loading
Precedente Chiudi:
$14.07
Aprire:
$14.11
Volume 24 ore:
670.08K
Relative Volume:
0.61
Capitalizzazione di mercato:
$11.88B
Reddito:
$3.85B
Utile/perdita netta:
$667.93M
Rapporto P/E:
21.65
EPS:
0.657
Flusso di cassa netto:
$142.30M
1 W Prestazione:
+0.32%
1M Prestazione:
-3.50%
6M Prestazione:
+5.77%
1 anno Prestazione:
-10.26%
Intervallo 1D:
Value
$14.11
$14.30
Intervallo di 1 settimana:
Value
$13.91
$14.47
Portata 52W:
Value
$12.26
$16.17

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
Nome
Dr Reddys Laboratories Ltd Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
27,811
Name
Cinguettio
@drreddys
Name
Prossima data di guadagno
2025-07-23
Name
Ultimi documenti SEC
Name
RDY's Discussions on Twitter

Confronta RDY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
14.22 11.63B 3.85B 667.93M 142.30M 0.657
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.08 63.58B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.91 43.58B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.205 40.83B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.75 23.07B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
430.14 19.61B 3.08B 1.24B 1.07B 25.61

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-05 Aggiornamento HSBC Securities Hold → Buy
2024-12-19 Downgrade Nomura Buy → Neutral
2024-01-11 Downgrade Jefferies Buy → Underperform
2023-08-29 Downgrade HSBC Securities Buy → Hold
2023-05-18 Downgrade Bernstein Outperform → Mkt Perform
2023-03-17 Aggiornamento BofA Securities Neutral → Buy
2023-01-30 Iniziato JP Morgan Underweight
2022-11-14 Downgrade Credit Suisse Neutral → Underperform
2022-01-03 Ripresa BofA Securities Neutral
2021-07-27 Downgrade Credit Suisse Outperform → Neutral
2021-02-02 Aggiornamento Barclays Equal Weight → Overweight
2020-09-18 Aggiornamento BofA Securities Neutral → Buy
2020-09-18 Aggiornamento Investec Sell → Hold
2020-01-28 Downgrade CLSA Buy → Outperform
2020-01-27 Downgrade CLSA Buy → Outperform
2020-01-09 Aggiornamento Citigroup Sell → Buy
2019-11-04 Downgrade BofA/Merrill Buy → Neutral
2019-09-04 Aggiornamento Credit Suisse Underperform → Outperform
2019-07-01 Aggiornamento Macquarie Neutral → Outperform
2019-06-20 Iniziato Deutsche Bank Hold
2019-06-11 Iniziato Barclays Equal Weight
2019-05-20 Downgrade Morgan Stanley Overweight → Equal-Weight
2019-02-19 Aggiornamento CLSA Outperform → Buy
2019-01-17 Downgrade Citigroup Neutral → Sell
2017-09-21 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2017-08-31 Aggiornamento CLSA Underperform → Outperform
2017-07-28 Downgrade CLSA Underperform → Sell
2016-07-27 Downgrade HSBC Securities Hold → Reduce
2016-07-27 Downgrade Jefferies Hold → Underperform
2016-02-10 Aggiornamento Credit Agricole Underperform → Buy
2015-11-10 Downgrade Citigroup Buy → Neutral
Mostra tutto

Dr Reddys Laboratories Ltd Adr Borsa (RDY) Ultime notizie

pulisher
Oct 11, 2025

Full Truck Alliance Co. Ltd. Sponsored ADR $YMM Shares Purchased by Mirae Asset Global Investments Co. Ltd. - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

Asian Stocks In The US Closed Lower This Week - Finimize

Oct 10, 2025
pulisher
Oct 09, 2025

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga

Oct 09, 2025
pulisher
Oct 09, 2025

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Sahm

Oct 09, 2025
pulisher
Oct 08, 2025

Truist Financial Corp Sells 21,444 Shares of Haleon PLC Sponsored ADR $HLN - Defense World

Oct 08, 2025
pulisher
Oct 02, 2025

Asian ADRs Rise As Regional Firms Show Mixed Performance - Finimize

Oct 02, 2025
pulisher
Sep 30, 2025

LLY Stock Quote Price and Forecast - CNN

Sep 30, 2025
pulisher
Sep 26, 2025

Dr Reddys Share Price Update: Company Reports Negative Monthly Returns - Meyka

Sep 26, 2025
pulisher
Sep 24, 2025

GDR, ADR & IDR Companies Stock Prices | IIFL Capital - India Infoline

Sep 24, 2025
pulisher
Sep 24, 2025

NVO Stock Quote Price and Forecast - CNN

Sep 24, 2025
pulisher
Sep 22, 2025

Asian ADRs In The US Start The Week On A High Note - Finimize

Sep 22, 2025
pulisher
Sep 20, 2025

Bizarre Stock Volatility? How Is H1B News Affecting Infosys & Wipro Share Prices On Saturday? - Free Press Journal

Sep 20, 2025
pulisher
Sep 17, 2025

Asian ADR Index Edges Up As LG Display Leads - Finimize

Sep 17, 2025
pulisher
Sep 16, 2025

Dr. Reddy’s Laboratories Allots Equity Shares Under Employee Stock Option Scheme - The Globe and Mail

Sep 16, 2025
pulisher
Sep 15, 2025

Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations - Business Standard

Sep 15, 2025
pulisher
Sep 11, 2025

Asian ADRs Gain As Investors Show Renewed Interest - Finimize

Sep 11, 2025
pulisher
Sep 10, 2025

Asian Equities In The US Logged Broad Gains This Session - Finimize

Sep 10, 2025
pulisher
Sep 03, 2025

Mixed Performance For Asian Stocks Traded In The US - Finimize

Sep 03, 2025
pulisher
Aug 29, 2025

Dr. Reddy’s Laboratories Allots Equity Shares to Employees - TipRanks

Aug 29, 2025
pulisher
Aug 26, 2025

Invesco Ltd. Has $8.12 Million Stake in ATRenew Inc. Sponsored ADR $RERE - Defense World

Aug 26, 2025
pulisher
Aug 25, 2025

Validea's Top Health Care Stocks Based On Peter Lynch8/25/2025 - Nasdaq

Aug 25, 2025
pulisher
Aug 25, 2025

Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - Barchart.com

Aug 25, 2025
pulisher
Aug 21, 2025

National Bank of Canada FI Boosts Stock Position in Dr. Reddy's Laboratories Ltd $RDY - MarketBeat

Aug 21, 2025
pulisher
Aug 20, 2025

Asian ADRs Trade Lower As S&P Asia 50 Index Drops - Finimize

Aug 20, 2025
pulisher
Aug 18, 2025

Asian Tech Names Lift US-Traded Stocks To A Small Gain - Finimize

Aug 18, 2025
pulisher
Aug 08, 2025

Dr. Reddy’s Subsidiary Imperial Dissolved Following NCLT Approval - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

(PDF) ADRs and underlying stock returns: empirical evidence from India - researchgate.net

Aug 07, 2025
pulisher
Aug 06, 2025

Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 50% Tariff On India - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Asian Stocks In The US See Mixed Moves Across Sectors - Finimize

Aug 06, 2025
pulisher
Aug 06, 2025

Trump hikes tariffs on India by additional 25% citing Russian oil trade; iShares India ETF, ADRs react - Moneycontrol

Aug 06, 2025
pulisher
Aug 02, 2025

Asian ADRs Fall As Winners And Losers Stand Out - Finimize

Aug 02, 2025
pulisher
Aug 01, 2025

Dr Reddys Laboratories Faces Continued Stock Decline Amid Broader Market Challenges - Markets Mojo

Aug 01, 2025
pulisher
Jul 31, 2025

Asian ADRs Falter On US Markets As Fintechs Slide - Finimize

Jul 31, 2025
pulisher
Jul 31, 2025

Trump’s Tariffs on India highlights: Sensex falls 800 points, Trump launches fresh attack on India for Russia ties - Mint

Jul 31, 2025
pulisher
Jul 30, 2025

Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 25% Tariff On India - MSN

Jul 30, 2025

Dr Reddys Laboratories Ltd Adr Azioni (RDY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$10.05
price up icon 0.75%
$58.60
price down icon 6.41%
$137.26
price down icon 0.44%
$20.39
price down icon 0.56%
$430.14
price down icon 0.45%
Capitalizzazione:     |  Volume (24 ore):